Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03621683
Other study ID # J298384255
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 6, 2016
Est. completion date August 28, 2017

Study information

Verified date August 2018
Source Fertiaguerrevere
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Two group of patients were selected. Group 1 represents 46 patients that received ovarian-biostimulation monthly for three months. Group 2 represents 32 patients that received antioxidant therapy daily for 3 months. Results are noted and analysed.

Both groups represent patients with procedures already ongoing, and with diagnosed poor or depleted ovarian reserve.

The analysis has been made to compare the efficacy of both procedures.


Description:

The bioestimulation group received a blood rich platelet therapy monthly for three months, with a technique developed by the laboratory. The second group of antioxidants received a combination of antioxidants monthly for three months. Both groups were compared to assess the results in terms of ovarian response (number of astral follicles, AMH levels, FSH, LH), and egg quality, embryo development, implantation rate, and successful pregnancy with healthy live birth.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date August 28, 2017
Est. primary completion date January 10, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 38 Years to 46 Years
Eligibility Inclusion Criteria:

- Age between 38 and 46 years

- FSH> 12 mIU

- Estradiol > 100 pg/ml

- AMH < 0.8 ng/mL

Exclusion Criteria:

- Pelvic inflammatory syndrome

- vaginal pathologies

- known history of hyperandrogenism

- diagnosed platelet disorders as adhesion

- aggregation

- disorder of thromboxane synthesis.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
blood rich plasma platelets
Injection of blood rich platelet into the ovaries.
Dietary Supplement:
Antioxidant therapy
Antioxidants: Q10, DHEA, Vitamina E, Vitamin C, Omega 3

Locations

Country Name City State
Venezuela Fertiaguerrevere Fertility Caracas Disfrito Federal

Sponsors (1)

Lead Sponsor Collaborator
Lucy Coleman

Country where clinical trial is conducted

Venezuela, 

References & Publications (8)

Bhartiya D, Parte S, Patel H, Sriraman K, Zaveri K, Hinduja I. Novel Action of FSH on Stem Cells in Adult Mammalian Ovary Induces Postnatal Oogenesis and Primordial Follicle Assembly. Stem Cells Int. 2016;2016:5096596. doi: 10.1155/2016/5096596. Epub 2015 — View Citation

Diamanti-Kandarakis E, Dattilo M, Macut D, Duntas L, Gonos ES, Goulis DG, Gantenbein CK, Kapetanou M, Koukkou E, Lambrinoudaki I, Michalaki M, Eftekhari-Nader S, Pasquali R, Peppa M, Tzanela M, Vassilatou E, Vryonidou A; COMBO ENDO TEAM: 2016. MECHANISMS — View Citation

Gat I, Blanco Mejia S, Balakier H, Librach CL, Claessens A, Ryan EA. The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve. Gynecol Endocrinol. 2016 Jul;32(7):534-7. doi: 10.3109/09513590.2015.1137095. Epub — View Citation

Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004 Mar 11;428(6979):145-50. Erratum in: Nature. 2004 Aug 26;430(7003):1062. — View Citation

Ozakpinar OB, Maurer AM, Ozsavci D. Ovarian stem cells: From basic to clinical applications. World J Stem Cells. 2015 May 26;7(4):757-68. doi: 10.4252/wjsc.v7.i4.757. Review. — View Citation

Özcan P, Fiçicioglu C, Kizilkale O, Yesiladali M, Tok OE, Ozkan F, Esrefoglu M. Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage? J Assist Reprod Genet. 2016 Sep;33(9):1223-30. doi: 10.1007/s10815-016-0751-z. Epub 2016 — View Citation

Pan Z, Sun M, Liang X, Li J, Zhou F, Zhong Z, Zheng Y. The Controversy, Challenges, and Potential Benefits of Putative Female Germline Stem Cells Research in Mammals. Stem Cells Int. 2016;2016:1728278. doi: 10.1155/2016/1728278. Epub 2015 Dec 15. Review. — View Citation

Telfer EE. Germline stem cells in the postnatal mammalian ovary: a phenomenon of prosimian primates and mice? Reprod Biol Endocrinol. 2004 May 18;2:24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary variation of hormones FSH and LH directly involved with ovarian reserve Both groups are compared after bio-stimulation and antioxidant therapy is performed to access any possible changes with FSH-LH post-treatment. 18 months
Primary variation of AMH directly involved with ovarian reserve in both groups Both groups are compared after bio-stimulation and antioxidant therapy is performed to access any possible changes with AMH values. 18 months
Primary variation in recruitment of antral follicles in both groups Both groups are compared after bio-stimulation and antioxidant therapy is performed to access any possible changes with the number of astral follicles available. 18 months
Secondary Number of good quality eggs obtained in both groups after IVF Egg quality is evaluated in both group of women undergoing IVF after bio-stimulation or antioxidant therapy are performed 18 months
Secondary Number and quality of fertilised eggs obtained in both groups after IVF the number and quality of fertilised eggs is evaluated in both groups of women undergoing IVF after bio-stimulation or antioxidant therapy is performed. 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT02896023 - Predictors of Ovarian Reserve in Infertile Women Phase 4
Recruiting NCT02240342 - Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve N/A
Completed NCT01268930 - Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas N/A
Completed NCT03492632 - Ovarian Reserve in Patients With Psoriasis
Withdrawn NCT02728245 - Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma Phase 2
Completed NCT05567731 - Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve N/A
Completed NCT03989921 - Ovarian Reserve and Embryo Implantation
Recruiting NCT02995343 - Evaluation of the Ovarian Reserve in Patients Who Hypogastric Arteries and or Uterine Arteries Had Been Ligated N/A
Withdrawn NCT01966536 - CD133 Transplantation to Generate Oocytes in Poor Ovarian Reserve N/A
Recruiting NCT04151173 - Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma N/A
Enrolling by invitation NCT02377128 - Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section N/A
Recruiting NCT03620838 - Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
Completed NCT02009228 - Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst. Phase 3
Completed NCT04762615 - Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Recruiting NCT03009370 - The Effect of the Ovarian Reserve on the Recurrent Pregnancy Loss N/A
Completed NCT04058678 - Effects of Telomerase Reactivation With Danazol in Ovarian Function. N/A
Recruiting NCT05743218 - Clinical Efficacy of Acupuncture on the Liver Meridian in Women With Diminished Ovarian Reserve N/A
Recruiting NCT04487925 - Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders Phase 4
Terminated NCT01114464 - Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer N/A
Active, not recruiting NCT00928044 - The Impact of Gynecological Surgery on Ovarian Function in Women of Reproductive Age: Postoperative Changes of Serum Anti-Müllerian Hormone (AMH) N/A